23605-23-4

Basic information

• Product Name: 2-CHLORO-N-CYCLOHEXYL-ACETAMIDE
• Synonyms: 2-CHLORO-N-CYCLOHEXYL-ACETAMIDE;AKOS BBS-00004074;AKOS B015663;CHEMBRDG-BB 3015663;ART-CHEM-BB B015663;2-CHLORO-N-CYCLOHEXYL-ACETAMIDE >97%;2-chloro-N-cyclohexyl-ethanamide;2-chloro-N-cyclohexylacetamide(SALTDATA: FREE)
• CAS NO: 23605-23-4
• Molecular Formula: C₈H₁₄ClNO
• Molecular Weight: 175.66
• Mol File: 23605-23-4.mol

Chemical Properties

• Melting Point: 109-111°C
• Boiling Point: 326.4 °C at 760 mmHg
• Flash Point: 151.2 °C
• Appearance: /
• Density: 1.1 g/cm³
• Vapor Pressure: 0.000216mmHg at 25°C
• Refractive Index: 1.484
• Storage Temp.: 2-8°C
• PKA: 13.97±0.20(Predicted)
• CAS DataBase Reference: 2-CHLORO-N-CYCLOHEXYL-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-N-CYCLOHEXYL-ACETAMIDE(23605-23-4)
• EPA Substance Registry System: 2-CHLORO-N-CYCLOHEXYL-ACETAMIDE(23605-23-4)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 23605-23-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-CHLORO-N-CYCLOHEXYL-ACETAMIDE serves as an intermediate in the synthesis of various drugs and pharmaceuticals, playing a crucial role in the development of new medications.
Used in Medicinal Chemistry Research:
It has been studied for its potential as an anticonvulsant and analgesic agent, indicating its use in the research and development of treatments for seizure disorders and pain management.
2-CHLORO-N-CYCLOHEXYL-ACETAMIDE is used as a chemical intermediate for [its role in the synthesis of pharmaceuticals] due to its structural properties that facilitate the creation of diverse drug molecules.
In Medicinal Chemistry Research:
2-CHLORO-N-CYCLOHEXYL-ACETAMIDE is used as a potential anticonvulsant and analgesic agent for [its possible therapeutic effects in managing seizures and pain], highlighting its utility in advancing treatment options for neurological conditions and pain relief.

InChI:InChI=1/C8H14ClNO/c9-6-8(11)10-7-4-2-1-3-5-7/h7H,1-6H2,(H,10,11)

Upstream product

• 4960-82-1 dichlorodiacetamide 
• 108-91-8 cyclohexylamine 
• 79-11-8 chloroacetic acid 
• 79-04-9 chloroacetyl chloride 
• 107-14-2 chloroacetonitrile 
• 108-93-0 cyclohexanol 
• 593-71-5 Chloroiodomethane 
• 3173-53-3 Cyclohexyl isocyanate 
• 75-36-5 acetyl chloride 
• 1440-61-5 N-chloroacetylmorpholine 
• 55112-46-4 3-hydroxy-2-(7-methoxy-[1,8]naphthyridin-2-yl)-2,3-dihydro-isoindol-1-one 
• 7572-29-4 dichloroethyne 
• 110-83-8 cyclohexene 

Downstream Products

• 21236-56-6 N,N-diethyl-glycine cyclohexylamide 
• 101881-32-7 ethylimino-di-acetic acid bis-cyclohexylamide 
• 92846-61-2 Di-O-methyl-S--dithiophosphat 
• 63237-95-6 4-amino-2-methylsulfanyl-thiazole-5-carboxylic acid cyclohexylamide 
• 118989-51-8 1,4-bis(cyclohexylaminocarbonylmethyl)piperazine 
• 118989-50-7 N-cyclohexyl-2-(4-methyl-1-piperazinyl)acetamide 
• 125983-69-9 2-(4-Chloro-phenylamino)-N-cyclohexyl-2-thioxo-acetamide 
• 163629-08-1 1-(cyclohexylaminocarbonylmethyl)-2-phenyl-indole 
• 73963-32-3 5-chloromethyl-1-cyclohexyl-1H-tetrazole 
• 6281-36-3 (2,3,4,6-tetrachloro-phenoxy)-acetic acid cyclohexylamide 
• 110506-25-7 N-cyclohexyl-2-(4-nitrophenoxy)acetamide 
• 101739-46-2 N-cyclohexyl-N-(2-dimethylamino-ethyl)-benzamide 
• 99178-21-9 N'-cyclohexyl-N,N-dimethyl-ethylenediamine 

Relevant articles and documents

Synthesis, characterization and evaluation of novel ferrocenylmethylamine derivatives as cytotoxic agents

The present report describes a new series of amide functionalized 20- and 30-aminomethylferrocene derived from ferrocenylmethylamine. The compounds 1a-5a and 1b-5b were characterized by microanalysis, 1H, 13C NMR, UV–visible, fluorescence, FTIR, thermogravimetric and crystallographic techniques. The X-ray analysis demonstrated the ability of these molecules to form various intermolecular hydrogen bonding interactions, as verified by Hirshfeld surface analysis. All the compounds were evaluated against MCF 7, IMR 32, HepG2 and immortal L132 cell lines by MTT assay and the results were compared with cisplatin. Interestingly, many compounds were very active against all the investigated cell lines and proved to be more potent as cytotoxic agents than cisplatin. The western blot, gene expression, mitochondrial membrane potential and flow cytometry study were used to investigate the mode of action of these derivatives as antitumor agents. The results showed apoptotic property of the compounds by modulating inflammatory pathway against human tumor cells of different origin. We performed the density functional theory calculations and molecular docking to rationalize the experimental results.

Sequence-Defined Dithiocarbamate Oligomers via a Scalable, Support-free, Iterative Strategy

Precise control over the monomeric sequence on natural sequence-defined polymers (SDPs) leads to their structural diversity and functions. However, absolute control over the monomeric sequence on a synthetic polymer remains a challenging process. Herein, we describe a support-free, protection-deprotection-free, cost-effective, and fast iterative strategy for multigram production of a new class of SDP with a unique functional group, dithiocarbamate, a potential group for material and biomedical applications. The strategy is based on a unique monomer, named as amine-hydroxyl monomer, and a three-component reaction between the monomer, CS2, and terminal chloro group of the growing chain. The fast strategy allows us to synthesize a 5-mer sequence-defined oligomer in 6 h. For a proof of concept, a range of aliphatic and aromatic groups have been incorporated at different sequences in the sequence-defined oligomer. This SDP platform has further been advanced by two ways: (i) multiple approaches for postsynthetic modification of SDP and (ii) increasing the chain length in a single step.

New Coumarin derivatives as cholinergic and cannabinoid system modulators

In the last years, the connection between the endocannabinoid system (eCS) and neuroprotection has been discovered, and evidence indicates that eCS signaling is involved in the regulation of cognitive processes and in the pathophysiology of Alzheimer’s di

De novo Design of SARS-CoV-2 Main Protease Inhibitors

The COVID-19 pandemic prompted many scientists to investigate remedies against SARS-CoV-2 and related viruses that are likely to appear in the future. As the main protease of the virus, M Pro, is highly conserved among coronaviruses, it has emerged as a prime target for developing inhibitors. Using a combination of virtual screening and molecular modeling, we identified small molecules that were easily accessible and could be quickly diversified. Biochemical assays confirmed a class of pyridones as low micromolar noncovalent inhibitors of the viral main protease.

Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics

Compounds for the treatment of hyperglycemia and/or diabetes are provided. The compounds, which inhibit the enzyme dipeptidyl peptidase (DPP-4), are based on the structure where n1=0-2 such as 0 or 1; R1 is i) a saturated or unsaturated, substituted or un

Palladium-Catalyzed β-C(sp3)-H Arylation of Aliphatic Ketones Enabled by a Transient Directing Group

The direct arylation of aliphatic ketones has been developed via Pd-catalyzed β-C(sp3)-H bond functionalization with 2-(aminooxy)-N,N-dimethylacetamide as a novel transient directing group (TDG), which showed remarkable directing ability to generate arylated products in moderate to good yields. Furthermore, the reaction can tolerate abundant substrate of ketones and aryl iodides. This study expands the scope of applications for TDGs.

Design, Synthesis, and Structure-Activity Relationship Studies of Novel Indolyalkylpiperazine Derivatives as Selective 5-HT1A Receptor Agonists

5-HT1A receptor (5-HT1AR) agonists have been implicated in the treatment of a variety of central nervous system (CNS) diseases such as depression and anxiety, et al. Based on our previously found compound FW01 (Ki = 51 ± 16 nM) obtained by virtual screening, a series of FW01 derivatives were designed and synthesized by the modification of the amide tail group as well as indole headgroup of FW01. SAR exploration found that amide tail group and indole headgroup play pivotal roles in determining the binding affinity and selectivity on dopamine and serotonin receptor subtypes. Among all tested compounds, 9_24 has a Ki value of 5 ± 0.6 nM with a good selectivity toward 5-HT1AR. The [35S] GTPγS assay showed that 9_24 is a full agonist toward 5-HT1AR with an EC50 value of 0.059 nM, which shows 266.2 and 146.4-fold selectivity to 5-HT2A and D3 respectively. Molecular dynamics simulations and molecular docking studies with 5-HT1AR-9_24 were performed to disclose the mechanism of its high activity and selectivity. Finally, a detailed stepwise 9_24 induced signal transduction mechanism of 5-HT1AR is proposed.

Design, Synthesis, and Bioactivity of α-Ketoamide Derivatives Bearing a Vanillin Skeleton for Crop Diseases

A series of novel α-ketoamide derivatives bearing a vanillin skeleton were designed and synthesized. Bioactivity tests on virus and bacteria were performed. The results indicated that some compounds exhibited excellent antitobacco mosaic virus (TMV) activities, such as compound 34 exhibited an inactivation activity of 90.1percent and curative activity of 51.8percent and compound 28 exhibited a curative activity of 54.8percent at 500 μg mL-1, which is equivalent to that of the commercial ningnanmycin (inactivation of 91.9percent and curative of 51.9percent). Moreover, the in vitro antibacterial activity test illustrated that compounds 2, 22, and 33 showed much higher activities than commercial thiodiazole copper, which could be used as lead compounds or potential candidates. The findings of transmission electron microscopy and molecular docking indicated that the synthesized compounds exhibited strong and significant binding affinity to the TMV coat protein and could obstruct the self-assembly and increment of TMV particles. This study revealed that α-ketoamide derivatives bearing a vanillin skeleton could be used as a novel potential pesticide for controlling the plant diseases.

ANTHRAQUINONIC DERIVATIVES AND THEIR USE AS COLOURING AGENTS

The present invention relates to a compound of formula (I-0) or a salt thereof. The invention further relates to the use of such compound as a colouring agent. The invention also relates to a colouring composition comprising such compound.

Continuous-Flow Electrosynthesis of Benzofused S-Heterocycles by Dehydrogenative C?S Cross-Coupling

Reported herein is the synthesis of benzofused six-membered S-heterocycles by intramolecular dehydrogenative C?S coupling using a modular flow electrolysis cell. The continuous-flow electrosynthesis not only ensures efficient product formation, but also obviates the need for transition-metal catalysts, oxidizing reagents, and supporting electrolytes. Reaction scale-up is conveniently achieved through extended electrolysis without changing the reaction conditions and equipment.